| J04AK02 |
J04AK02 Ethambutol |
| J04AK03 |
J04AK03 Terizidone |
| J04AK04 |
J04AK04 Morinamide |
| J04AK05 |
J04AK05 Bedaquiline |
| J04AK06 |
J04AK06 Delamanid |
| J04AK07 |
J04AK07 Thioacetazone |
| J04AK08 |
J04AK08 Pretomane |
| J04AM |
J04AM Combinations Of Drugs For Treatment Of Tuberculosis |
| J04AM01 |
J04AM01 Streptomycin And Isoniazid |
| J04AM02 |
J04AM02 Rifampicin And Isoniazid |
| J04AM03 |
J04AM03 Ethambutol And Isoniazid |
| J04AM04 |
J04AM04 Thioacetazone And Isoniazid |
| J04AM05 |
J04AM05 Rifampicin, Pyrazinamide And Isoniazid |
| J04AM06 |
J04AM06 Rifampicin, Pyrazinamide, Ethambutol And Isoniazid |
| J04AM07 |
J04AM07 rifampicin, ethambutol and isoniazid |
| J04AM08 |
J04AM08 isoniazid, sulfamethoxazole, trimethoprim and pyridoxine |
| J04B |
J04B Drugs For Treatment Of Lepra |
| J04BA |
J04BA Drugs For Treatment Of Lepra |
| J04BA01 |
J04BA01 Clofazimine |
| J04BA02 |
J04BA02 Dapsone |
| J04BA03 |
J04BA03 Aldesulfone sodium |
| J05 |
J05 Antivirals for systemic use |
| J05A |
J05A Direct acting antiviral drugs |
| J05AA |
J05AA Thiosemicarbazones |
| J05AA01 |
J05AA01 Metisazone |
| J05AB |
J05AB Nucleosides and nucleotides excluding reverse transcriptase inhibitors |
| J05AB01 |
J05AB01 Aciclovir |
| J05AB02 |
J05AB02 Idoxuridine |
| J05AB03 |
J05AB03 Vidarabine |
| J05AB04 |
J05AB04 Ribavirin |